Saltar al contenido
Merck
  • Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting.

Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting.

European journal of nuclear medicine and molecular imaging (2006-06-10)
Cristina Müller, Alexander Hohn, P August Schubiger, Roger Schibli
RESUMEN

The folate receptor (FR) is a valuable tumour marker, since it is frequently overexpressed on various cancer types. The purpose of the present study was to pre-clinically evaluate novel site-specifically modified (99m)Tc(CO)(3) folate (gamma-derivative 4, alpha-derivative 5) and pteroate (6) conjugates for FR targeting. The (99m)Tc(CO)(3) radiotracers 4-6 were prepared by a kit-like procedure. In vitro characterisation (K (D) and B (max)) of the radiotracers was performed with FR-positive KB cells. Tissue distribution was studied in tumour-bearing mice. SPECT/CT experiments were performed with a dedicated small animal SPECT/CT scanner. The complexes 4-6 were formed in high yields (>92%). Binding constants of the radiotracers (K (D) in nM: 4: 2.09; 5: 2.51; 6: 14.52) were similar to those of (3)H-folic acid (K (D) in nM: 7.22). In vivo the folate derivatives showed significantly better tumour uptake (4: 2.3+/-0.4% ID/g and 5: 1.2+/-0.2% ID/g, 4 h p.i.) than the pteroate derivative (6: 0.4+/-0.2% ID/g, 4 h p.i.). Clearance of all radiotracers from the blood pool and from non-targeted tissues was efficient (tumour to blood ratio approx. 200-350, 24 h p.i.). FR-positive tissue and organs were successfully visualised via small animal SPECT/CT. Radiotracers 4-6 are the first (99m)Tc(CO)(3) tracers prepared via a kit formulation which exhibit full biological activity in vitro and in vivo. Folate derivatives 4 and 5 revealed significantly better pharmacokinetic properties than the pteroate derivative 6. Promising pre-clinical SPECT results warrant further assessment of (99m)Tc(CO)(3) radiofolates for detection of FR-positive tumours.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Pteroic acid, ≥93%
Número de referencia del producto (SKU)
Tamaño de envase
Disponibilidad
Precio
Cantidad
Folic acid impurity D, European Pharmacopoeia (EP) Reference Standard
Número de referencia del producto (SKU)
Tamaño de envase
Disponibilidad
Precio
Cantidad